Vickers Vantage Corp. I

Completed

Follow

Detailed Information

Information on this SPAC.

Sponsors: Vickers Venture Fund VI
Vickers Venture Fund VI (Plan)
IPO Size: $100M
Underwriters: Maxim Group
B. Riley
SEC Filings: 1820190
Public Embarc Page: https://embarc.com/capital/spac/1820190/VCKA/vickers-vantage
IPO Ticker: VCKA

SPAC Leadership

Information on the SPAC leadership.

Chairman and Chief Executive OfficerJeffrey Chi
Chief Financial Officer and DirectorChris Ho
DirectorPei Wei Woo
DirectorSuneel Kaji
DirectorSteve Myint
Finian Tan

Target Information

Information on the SPAC target for merger.

Company: Scilex
Presentation: Investor Presentation (SEC) on 2022-03-21
New Ticker: SCLX VCKAU VCKAW
Description: Scilex is "dedicated to the development and commercialization of non-opioid pain management products for treatment of acute and chronic pain."